Process Development for Lyophilized Products

Publisher: Baxter BioPharma Solutions

Access this content

Your content has been opened.

Please verify you are a human before downloading this content.

Process Development for Lyophilized Products has been emailed to . Entered the wrong email?

Don't see the content in your inbox?
Make sure to check your spam and other messages folders.

Can't get to your email right now?

To complete your registration and access this content, enter the sign-in code sent to your email.

Please enter a valid verification code.

Code sent to:

Also, remember to check in your spam, promotions, and other folders.


Register to access this content


By accessing content on the Pharmaceutical Manufacturing Resource Directory you agree to our Terms of Service and Privacy Policy; and, you acknowledge that your information may be shared with the content publisher.

Process Development for Lyophilized Products

Baxter BioPharma Solutions approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails enables the development scientist to design a formulation and process with meaningful ranges supported by data. This document describes the approach to process development for lyophilized products conducted at Baxter.